Dr. Piatek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
# NOR8302E
Los Angeles, CA 90089Phone+1 323-865-3105
Education & Training
- University of Southern California/LAC+USC Medical CenterFellowship, Hematology, 2012 - 2015
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2009 - 2012
- Creighton University School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2010 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Study of Fostamatinib Disodium in the Treatment of wAIHA Start of enrollment: 2019 Apr 24
Publications & Presentations
PubMed
- 1 citationsLong-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.Austin Kulasekararaj, Morag Griffin, Caroline Piatek, Jamile Shammo, Jun-Ichi Nishimura
Blood. 2025-02-20 - Ravulizumab demonstrates long-term efficacy, safety and favorable patient survival in patients with paroxysmal nocturnal hemoglobinuria.Austin Kulasekararaj, Robert Brodsky, Hubert Schrezenmeier, Morag Griffin, Alexander Röth
Annals of Hematology. 2025-01-01 - 11 citationsFostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).David J Kuter, Caroline Piatek, Alexander Röth, Asif Siddiqui, Robert P Numerof
American Journal of Hematology. 2024-01-01
Press Mentions
- Rigel Reports First Quarter 2022 Financial Results and Provides Business UpdateMay 3rd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: